Literature DB >> 3474439

Concurrent measurements of blood flow and transcapillary transport in xenotransplanted human gliomas in immunosuppressed rats.

F J Vriesendorp, C Peagram, D D Bigner, D R Groothuis.   

Abstract

Neonatal Fischer 344 rats were immunosuppressed with antithymocyte serum and later were given an injection intracerebrally of cells from the human glioma permanent line D-54MG. Symptomatic tumor-bearing rats were studied with double-label quantitative autoradiography to concurrently measure blood flow and a unidirectional blood-to-tissue transfer constant (K) for alpha-aminoisobutyric acid (AIB). A net extraction fraction (En) was calculated from the measured values for blood flow and K. Mean whole tumor blood flow was 53.5 +/- 4.9 ml/100 g/min (mean +/- SEM), which was significantly less than the blood flow to the tumor-free cortex (198 +/- 15.5 ml/100 g/min) but not significantly different from the blood flow in the tumor-free corpus callosum (50.6 +/- 4.3 ml/100 g/min). Mean whole tumor K-value for AIB was 5.8 +/- 0.5 ml/100 g/min, approximately 30 times the K-value for tumor-free brain. The calculated mean whole tumor En was 0.2 +/- 0.09, nearly 100 times the value for the tumor-free brain. Regionally, blood flow was lower in the tumor center and higher in its tumor periphery, although the difference was not significant. Both K- and En-values were significantly higher for the tumor center and decreased radially for the areas from center out. The values for K and En of AIB in the D-54MG gliomas are the highest of any experimental brain tumor model studied to date and indicate that in some tumor regions in this model, blood-to-tissue transport of the water-soluble compound AIB may be dependent on blood flow as well as on the permeability-surface area product of the tumor capillaries.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474439

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

Review 1.  Blood flow and metabolic microenvironment of brain tumors.

Authors:  P Vaupel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  Noisy intracranial tumours.

Authors:  B T van Dooren; A C van Bruggen; J J Mooij; J M Hew; H L Journée
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

3.  Isolation of drug delivery from drug effect: problems of optimizing drug delivery parameters.

Authors:  Mir J Ali; Yot Navalitloha; Michael W Vavra; Eric W-Y Kang; Andrea C Itskovich; Peter Molnar; Robert M Levy; Dennis R Groothuis
Journal:  Neuro Oncol       Date:  2006-03-08       Impact factor: 12.300

Review 4.  Image-guided 1H NMR spectroscopical and histological characterization of a human brain tumor model in the nude rat; a new approach to monitor changes in tumor metabolism.

Authors:  H J Bernsen; A Heerschap; A J van der Kogel; J J van Vaals; M J Prick; E F Poels; J Meyer; J A Grotenhuis
Journal:  J Neurooncol       Date:  1992-06       Impact factor: 4.130

5.  Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat.

Authors:  P A Barnett; S Roman-Goldstein; F Ramsey; C I McCormick; G Sexton; J Szumowski; E A Neuwelt
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

6.  The effect of systemic arterial hypertension on blood-to-tissue transport in experimental gliomas.

Authors:  F J Vriesendorp; J F Pasternak; D R Groothuis
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 7.  Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.

Authors:  R D Fross; P C Warnke; D R Groothuis
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

8.  Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice.

Authors:  R D Zhang; J E Price; T Fujimaki; C D Bucana; I J Fidler
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.